CTAS AI Stock Analysis – Buy, Hold, or Avoid?

5 left

Cintas Corporation (CTAS)

$165.42+0.75 (+0.46%) today

Open
$166.22
High
$167.77
Low
$164.70
Volume
1.68M
Mkt Cap
$66.18B
52W High
$229.24
AI Verdict
Confidence 70%
CTASCintas Corporation
AlphaCrew AI
HOLD
Overall
Summary

Cintas (CTAS) is a fundamentally strong, market-leading company trading near its 52-week low, but faces technical weakness, premium valuation, and mixed sentiment amid acquisition and macro risks. While long-term prospects remain attractive due to recurring revenue and operational excellence, near-term downside risk and lack of technical support warrant caution. Investors should monitor acquisition progress and margin trends before considering new positions.

By Timeframe
Hover for details
WAIT
Short
HOLD
Medium
HOLD
Long
Agent Signals
41
Fund
Tech
Val
Sent
Risk

Fundamentals

Essentia
Essentia
Fundamental Analysis
NEUTRAL

The fundamental data and earnings history for Cintas (CTAS) could not be retrieved at this moment, restricting a detailed quantitative analysis. However, CTAS remains a recognized industry leader with a resilient business model, robust cash flow generation, and a track record of steady growth. Market data suggests the company trades at a premium valuation relative to its historical average, reflecting market confidence in its fundamentals.

Financial Highlights

Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026$0$750.0M$1.5B$2.3B$3.0BRevenue & Net Income ($)16.8%17.15%17.5%17.85%18.2%Net Margin (%)
  • Revenue
  • Net Income
  • Net Margin (%)

Revenue

$2.84B

8.90% YoY

Q1 2026

Net Income

$502.50M

8.41% YoY

Q1 2026

Net Margin

17.68%

Q1 2026

Growth Metrics

Revenue Growth YoY

8.90%

Latest Quarter: Q1 2026

Net Income Growth YoY

8.41%

Latest Quarter: Q1 2026

Revenue Per Share Growth YoY

9.48%

Latest Quarter: Q1 2026

EPS Growth YoY

10.53%

Latest Quarter: Q1 2026

Book Value Per Share Growth YoY

4.83%

Latest Quarter: Q1 2026

 Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024
Revenue2.8B2.8B2.7B2.7B2.6B2.6B2.5B2.5B
Revenue Growth YoY+8.90%+9.30%+8.66%+7.96%+8.44%+7.77%+6.80%+8.16%
Net Income502.5M495.3M491.1M448.3M463.5M448.5M452.0M414.3M
Net Income Growth YoY+8.41%+10.45%+8.65%+8.19%+16.58%+19.72%+17.39%+19.67%
EPS$1.26$1.23$1.21$1.11$1.14$1.11$1.12$1.02
EPS Growth YoY+10.53%+10.81%+8.04%+8.82%+16.33%+20.65%+19.15%+20.00%

Profitability Metrics

Gross Margin

50.98%

TTM

Operating Margin

23.22%

TTM

Net Margin

17.68%

TTM

Return on Equity

41.47%

TTM

Return on Assets

30.04%

TTM

 Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024
Gross Margin50.98%50.45%50.28%49.71%50.57%49.84%50.05%47.50%
Operating Margin23.22%23.42%22.73%22.40%23.37%23.09%22.43%22.16%
Net Margin17.68%17.69%18.07%16.80%17.76%17.51%18.07%16.77%
Return on Equity (ROE)10.49%11.12%10.33%9.57%10.09%10.45%11.24%9.60%
Return on Assets (ROA)7.79%7.80%8.01%7.33%8.04%8.07%8.40%7.16%

Technical Analysis

Candela
Candela
Technical Analysis
BEARISH

CTAS is currently in a strong downtrend exhibiting a Stage 4 declining phase, with price trading well below all major moving averages (50, 150, and 200 SMA). Momentum indicators reflect weak trend strength with RSI in neutral territory and ADX signaling no strong trend, suggesting price may be range-bound or consolidating within this bearish context.

RSI
Hold
Neutral34

No extreme reading

03070100
Trend
Sell
Strong Downtrend

Price in downtrend

-14.1% from 200 SMA
ADX
Hold
Weak/No Trend18

Range-bound market

Weak
MA Cross
Sell
Below 50/200

50 below 200 - bearish

50
200

Key Technical Values

Price
$165.42
50 SMA
$179.05
150 SMA
$186.41
200 SMA
$192.50
52W High
$229.24
52W Low
$163.45

Price with Moving Averages

50-day, 150-day and 200-day simple moving averages

Price
50 SMA
150 SMA
200 SMA

Relative Strength Index

Momentum oscillator measuring speed and magnitude of price changes

RSI (14)

≤30 Oversold
≥70 Overbought
34Neutral

Earnings

Essentia
Essentia
Fundamental Analysis
NEUTRAL

The fundamental data and earnings history for Cintas (CTAS) could not be retrieved at this moment, restricting a detailed quantitative analysis. However, CTAS remains a recognized industry leader with a resilient business model, robust cash flow generation, and a track record of steady growth. Market data suggests the company trades at a premium valuation relative to its historical average, reflecting market confidence in its fundamentals.

Latest Earnings

Q1 2026 Earnings (Feb 28, 2026)

Earnings Per Share (EPS)

Met

Actual

$1.24

Estimated

$1.24

Surprise

$0.00

Surprise %

0.00%

Revenue

Beat

Actual

$2.84B

Estimated

$2.82B

Surprise

+$20.54M

Surprise %

+0.73%

Historical Earnings

 Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024
Earnings Per Share
EPS (Actual)$1.24$1.21$1.20$1.09$1.13$1.09$1.10$1.00
EPS (Estimated)$1.24$1.20$1.19$1.07$1.07$1.01$0.95$0.95
EPS Surprise+$0.00+$0.01+$0.01+$0.02+$0.06+$0.08+$0.15+$0.05
% Diff+0.0%+0.8%+0.8%+1.9%+5.6%+7.9%+15.8%+5.4%
Revenue
Revenue (Actual)$2.84B$2.8B$2.72B$2.67B$2.61B$2.56B$2.5B$2.47B
Revenue (Estimated)$2.82B$2.77B$2.7B$2.63B$2.6B$2.56B$2.49B$2.47B
Revenue Surprise+$20.54M+$34.54M+$19.66M+$41.66M+$11.97M-$275.66K+$7.72M+$2.23M
% Diff+0.7%+1.2%+0.7%+1.6%+0.5%-0.0%+0.3%+0.1%

Valuation

Valorem
Valorem
Valuation Analysis

Cintas Corporation is currently trading near its 52-week low with a mixed valuation profile, showing solid financial health and steady growth but stretched valuation multiples compared to sector peers. Analysts maintain a consensus Hold rating with upside potential tied to earnings growth and revenue outperformance versus industry averages. Market sentiment is cautious due to recent insider selling and near-term technical weakness.

Valuation Metrics

Price to Earnings

34.29

TTM

Price to Sales

6.00

TTM

Price to Book

13.87

TTM

Enterprise Value to EBITDA

23.68

TTM

Enterprise Value to Revenue

6.25

TTM

 Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024
Price to Earnings40.1937.5743.1250.9645.1951.6944.9041.54
Price to Sales28.4326.5931.1634.2532.1136.2032.4627.86
Price to Book16.8716.7117.8119.5118.2421.6020.1915.95
Enterprise Value to EBITDA126.5598.93116.94129.98116.48127.72123.51106.51
Enterprise Value to Revenue29.3927.6732.1035.1533.0537.2633.5528.80

Sentiment & Analyst Ratings

Pulse
Pulse
Sentiment Analysis
MIXED

Cintas Corporation (CTAS) sentiment is currently mixed, reflecting divided analyst opinions and cautious investor sentiment. While the company demonstrates strong revenue growth and operational efficiency, concerns about high valuation, customer churn, and potential EPS decline create headwinds. Recent news highlights the strategic UniFirst acquisition and steady financial performance amid a market correction.

Analyst Recommendations

As of May 1, 2026
Strong SellSellHoldBuyStrong Buy
Hold
3.4 / 5.0
Based on 21 analyst ratings
Strong Sell
0
Sell
2
Hold
10
Buy
7
Strong Buy
2

Risk Assessment

Sentinel
Sentinel
Risk Assessment
MODERATE

Cintas Corporation demonstrates a solid financial position with robust liquidity and moderate leverage as it navigates a complex regulatory and competitive landscape. While recent organic revenue growth and operational performance are strong, upcoming acquisition-related risks and premium valuation require cautious investor consideration. Near-term liquidity remains healthy, but enhanced debt levels from the UniFirst acquisition introduce longer-term leverage considerations.

Liquidity & Solvency

Current Ratio

1.98

Latest Quarter: Q1 2026

Quick Ratio

1.74

Latest Quarter: Q1 2026

Debt-to-Equity

0.61

Latest Quarter: Q1 2026

Debt-to-Assets

0.29

Latest Quarter: Q1 2026

 Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024
Liquidity Metrics
Current Ratio1.981.712.242.091.110.990.951.12
Quick Ratio1.741.491.941.820.890.790.750.90
Solvency Metrics
Debt-to-Equity0.610.730.560.570.590.660.710.62
Debt-to-Assets0.290.320.270.270.280.300.310.28

Liquidity Assessment

Current Ratio: 1.98(Strong)

Quick Ratio: 1.74(Strong)

The company has strong liquidity with sufficient short-term assets to cover liabilities.

Solvency Assessment

Debt-to-Equity: 0.61(Moderate)

Debt-to-Assets: 0.29(Low)

The company maintains a balanced capital structure with manageable debt levels.

Frequently Asked Questions about CTAS

AI Answers: Common Questions About CTAS

Get AI-powered answers to the questions investors ask most about Cintas Corporation

CTAS is trading near its 52-week low ($165.46) with a P/E of 35.83 and high EV/EBITDA, reflecting premium pricing for its growth and quality. While the business is fundamentally strong, the current technical downtrend and mixed sentiment suggest it is not an ideal buy right now; waiting for technical stabilization or a better entry point is advised.

If you already own CTAS, there is no urgent reason to sell given the company's strong fundamentals, but the technical downtrend and deteriorating sentiment warrant caution. Consider reducing exposure if the stock breaks below $165.46 with high volume, or if acquisition/regulatory risks escalate.

The biggest risks are premium valuation (P/E 35.83, EV/EBITDA high), integration and regulatory uncertainty from the UniFirst acquisition, and potential margin compression from labor and macro headwinds. Sentinel notes debt-to-equity at 0.61 and debt at 28.5% of assets, which could rise post-acquisition.

Analyst consensus price target is around $213, implying moderate upside from current levels, but technical resistance at $180.50 (50 SMA) and $193.08 (200 SMA) must be cleared first. Downside support is at $165.46; a break below this could trigger further declines.

CTAS is fairly valued relative to its own history but expensive versus sector peers, with a P/E of 35.83 and high EV/EBITDA and P/B ratios. The premium is justified by high ROE (>40%) and cash flow, but limits near-term upside unless earnings accelerate.

CTAS is fundamentally strong, with high recurring revenue, superior margins, ROE regularly above 25%, and a robust balance sheet (current ratio ~2.0, quick ratio >1.7). Earnings growth is steady, driven by both organic expansion and disciplined acquisitions.

Technical analysis is bearish: the stock is in a Stage 4 downtrend, below all major moving averages, with a death cross and RSI around 35. No reversal patterns are present, and support is only at the 52-week low ($165.46); further downside is possible if this breaks.

Key catalysts include regulatory approval and integration of the UniFirst acquisition, upcoming earnings reports (with potential for guidance changes), and any signs of margin improvement or macro stabilization. Watch for volume spikes or technical base formation as signals of a trend change.

Want a Personalized Answer?

Get AI-powered insights tailored to your risk tolerance and investment goals.

More AI Stock Analyses